Evidence map›Paper›PMID 26918198›Full record

ArticleJournal of nanomedicine & nanotechnology2014

Nanoengineered Platforms to Guide Pluripotent Stem Cell Fate.

Katy Rutledge, Ehsan Jabbarzadeh

Abstract read
In one paragraph

Article in Journal of nanomedicine & nanotechnology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Katy RutledgeDepartment of Chemical Engineering, University of South Carolina, Columbia, SC, 29208, USA.
Ehsan JabbarzadehDepartment of Chemical Engineering, University of South Carolina, Columbia, SC, 29208, USA; Biomedical Engineering Program, University of South Carolina, Columbia, SC, 29208, USA; Department of Orthopaedic Surgery, University of South Carolina School of Medicine, Columbia, SC, 29209, USA.

Funding

Targeting early ceramide elevation in pre-symptomatic eczemaP20GM103641 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI ENOS, REILLY, NAGARKATTI, PRAKASH S · 2012 to 2023
$20.7M
NIGMS NIH HHS P20 GM103641
6 · The paper itself

Abstract

Tissue engineering utilizes cells, signaling molecules, and scaffolds towards creating functional tissue to repair damaged organs. Pluripotent stem cells (PSCs) are a promising cell source due to their ability to self-renewal indefinitely and their potential to differentiate into almost any cell type. Great strides have been taken to parse the physiological mechanisms by which PSCs respond to their microenvironment and commit to a specific lineage. The combination of physical cues and chemical factors is thought to have the most profound influence on stem cell behavior, therefore a major focus of tissue engineering strategies is scaffold design to incorporate these signals. One overlooked component of the

Indexed as

Cell shapeEmbryonic stem cellsInduced pluripotent stem cellsNanotechnologyPhysical signalsStem cell microenvironmentSurface topography

Identifiers

PMID26918198
PMCPMC4764045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.